• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

序数型SuStaIn:临床评分、视觉评级及其他序数数据的亚型和阶段推断

Ordinal SuStaIn: Subtype and Stage Inference for Clinical Scores, Visual Ratings, and Other Ordinal Data.

作者信息

Young Alexandra L, Vogel Jacob W, Aksman Leon M, Wijeratne Peter A, Eshaghi Arman, Oxtoby Neil P, Williams Steven C R, Alexander Daniel C

机构信息

Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Centre for Medical Image Computing, University College London, London, United Kingdom.

出版信息

Front Artif Intell. 2021 Aug 12;4:613261. doi: 10.3389/frai.2021.613261. eCollection 2021.

DOI:10.3389/frai.2021.613261
PMID:34458723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8387598/
Abstract

Subtype and Stage Inference (SuStaIn) is an unsupervised learning algorithm that uniquely enables the identification of subgroups of individuals with distinct pseudo-temporal disease progression patterns from cross-sectional datasets. SuStaIn has been used to identify data-driven subgroups and perform patient stratification in neurodegenerative diseases and in lung diseases from continuous biomarker measurements predominantly obtained from imaging. However, the SuStaIn algorithm is not currently applicable to discrete ordinal data, such as visual ratings of images, neuropathological ratings, and clinical and neuropsychological test scores, restricting the applicability of SuStaIn to a narrower range of settings. Here we propose 'Ordinal SuStaIn', an ordinal version of the SuStaIn algorithm that uses a scored events model of disease progression to enable the application of SuStaIn to ordinal data. We demonstrate the validity of Ordinal SuStaIn by benchmarking the performance of the algorithm on simulated data. We further demonstrate that Ordinal SuStaIn out-performs the existing continuous version of SuStaIn (Z-score SuStaIn) on discrete scored data, providing much more accurate subtype progression patterns, better subtyping and staging of individuals, and accurate uncertainty estimates. We then apply Ordinal SuStaIn to six different sub-scales of the Clinical Dementia Rating scale (CDR) using data from the Alzheimer's disease Neuroimaging Initiative (ADNI) study to identify individuals with distinct patterns of functional decline. Using data from 819 ADNI1 participants we identified three distinct CDR subtype progression patterns, which were independently verified using data from 790 ADNI2 participants. Our results provide insight into patterns of decline in daily activities in Alzheimer's disease and a mechanism for stratifying individuals into groups with difficulties in different domains. Ordinal SuStaIn is broadly applicable across different types of ratings data, including visual ratings from imaging, neuropathological ratings and clinical or behavioural ratings data.

摘要

亚型和阶段推断(SuStaIn)是一种无监督学习算法,它能够从横断面数据集中唯一地识别出具有不同伪时间疾病进展模式的个体亚组。SuStaIn已被用于从主要通过成像获得的连续生物标志物测量中识别数据驱动的亚组,并在神经退行性疾病和肺部疾病中进行患者分层。然而,SuStaIn算法目前不适用于离散有序数据,如图像的视觉评分、神经病理学评分以及临床和神经心理学测试分数,这限制了SuStaIn在更窄范围内的适用性。在此,我们提出“有序SuStaIn”,这是SuStaIn算法的有序版本,它使用疾病进展的计分事件模型,使SuStaIn能够应用于有序数据。我们通过在模拟数据上对算法性能进行基准测试,证明了有序SuStaIn的有效性。我们进一步证明,在离散计分数据上,有序SuStaIn优于现有的连续版本的SuStaIn(Z分数SuStaIn),能提供更准确的亚型进展模式、更好的个体亚型划分和分期,以及准确的不确定性估计。然后,我们使用来自阿尔茨海默病神经影像倡议(ADNI)研究的数据,将有序SuStaIn应用于临床痴呆评定量表(CDR)的六个不同子量表,以识别功能衰退模式不同的个体。利用来自819名ADNI1参与者的数据,我们识别出三种不同的CDR亚型进展模式,并使用来自790名ADNI2参与者的数据进行了独立验证。我们的结果为阿尔茨海默病日常活动衰退模式提供了见解,并为将个体分层为不同领域有困难的群体提供了一种机制。有序SuStaIn广泛适用于不同类型的评分数据,包括来自成像的视觉评分、神经病理学评分以及临床或行为评分数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/c624a953b2fc/frai-04-613261-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/1de033c608b4/frai-04-613261-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/67568b597882/frai-04-613261-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/29b0e0f03798/frai-04-613261-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/314bee827e80/frai-04-613261-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/6bb4c4de1ad6/frai-04-613261-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/dc8f89d825e1/frai-04-613261-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/f7dc1bba5709/frai-04-613261-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/c624a953b2fc/frai-04-613261-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/1de033c608b4/frai-04-613261-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/67568b597882/frai-04-613261-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/29b0e0f03798/frai-04-613261-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/314bee827e80/frai-04-613261-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/6bb4c4de1ad6/frai-04-613261-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/dc8f89d825e1/frai-04-613261-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/f7dc1bba5709/frai-04-613261-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d198/8387598/c624a953b2fc/frai-04-613261-g008.jpg

相似文献

1
Ordinal SuStaIn: Subtype and Stage Inference for Clinical Scores, Visual Ratings, and Other Ordinal Data.序数型SuStaIn:临床评分、视觉评级及其他序数数据的亚型和阶段推断
Front Artif Intell. 2021 Aug 12;4:613261. doi: 10.3389/frai.2021.613261. eCollection 2021.
2
Multimodal subtypes identified in Alzheimer's Disease Neuroimaging Initiative participants by missing-data-enabled subtype and stage inference.通过启用缺失数据的亚型和阶段推断在阿尔茨海默病神经影像倡议参与者中识别出的多模态亚型。
Brain Commun. 2024 Jun 25;6(4):fcae219. doi: 10.1093/braincomms/fcae219. eCollection 2024.
3
Heterogeneity in Preclinical Alzheimer's Disease Trial Cohort Identified by Image-based Data-Driven Disease Progression Modelling.通过基于图像的数据驱动疾病进展建模确定的临床前阿尔茨海默病试验队列中的异质性
medRxiv. 2023 Feb 10:2023.02.07.23285572. doi: 10.1101/2023.02.07.23285572.
4
Inter-Cohort Validation of SuStaIn Model for Alzheimer's Disease.阿尔茨海默病SuStaIn模型的队列间验证
Front Big Data. 2021 May 20;4:661110. doi: 10.3389/fdata.2021.661110. eCollection 2021.
5
Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson's disease.帕金森病中脑萎缩三个不同时空模式的描绘。
Brain. 2024 Nov 4;147(11):3702-3713. doi: 10.1093/brain/awae303.
6
Transferability of Alzheimer's disease progression subtypes to an independent population cohort.阿尔茨海默病进展亚型向独立人群队列的可转移性。
Neuroimage. 2023 May 1;271:120005. doi: 10.1016/j.neuroimage.2023.120005. Epub 2023 Mar 11.
7
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.记忆门诊环境中萎缩异质性和进展的可推广数据驱动模型。
Brain. 2024 Jul 5;147(7):2400-2413. doi: 10.1093/brain/awae118.
8
Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.阿尔茨海默病进展多项指标的纵向暴露-反应建模。
J Prev Alzheimers Dis. 2023;10(2):212-222. doi: 10.14283/jpad.2023.13.
9
Patterns of Glucose Metabolism in [ F]FDG PET Indicate Regional Variability and Neurodegeneration in the Progression of Alzheimer's Dementia.[¹⁸F]FDG PET 中的葡萄糖代谢模式表明阿尔茨海默病痴呆进展中的区域变异性和神经退行性变。
medRxiv. 2023 Nov 11:2023.11.10.23298396. doi: 10.1101/2023.11.10.23298396.
10
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.利用亚型和阶段推断揭示神经退行性疾病的异质性和时间复杂性。
Nat Commun. 2018 Oct 15;9(1):4273. doi: 10.1038/s41467-018-05892-0.

引用本文的文献

1
Elucidating Development Trajectories of Brain Functional Abnormalities in Major Depressive Disorder Utilizing a Data-Driven Disease Progression Model.利用数据驱动的疾病进展模型阐明重度抑郁症脑功能异常的发展轨迹
Hum Brain Mapp. 2025 Jun 1;46(8):e70249. doi: 10.1002/hbm.70249.
2
Sympathetic and parasympathetic subtypes of body-first Lewy body disease observed in postmortem tissue from prediagnostic individuals.在生前未诊断个体的尸检组织中观察到的身体优先型路易体病的交感神经和副交感神经亚型。
Nat Neurosci. 2025 May;28(5):925-936. doi: 10.1038/s41593-025-01910-9. Epub 2025 Mar 13.
3
Modeling Liver Fibrosis Progression in Patients With Viral Hepatitis Using the Machine Learning Tool Subtype and Stage Inference (SuStaIn).

本文引用的文献

1
Characterizing the Clinical Features and Atrophy Patterns of -Related Frontotemporal Dementia With Disease Progression Modeling.探讨疾病进展建模与 -相关额颞叶痴呆的临床特征和萎缩模式。
Neurology. 2021 Aug 31;97(9):e941-e952. doi: 10.1212/WNL.0000000000012410. Epub 2021 Jun 22.
2
Four distinct trajectories of tau deposition identified in Alzheimer's disease.阿尔茨海默病中tau 沉积的四种不同轨迹。
Nat Med. 2021 May;27(5):871-881. doi: 10.1038/s41591-021-01309-6. Epub 2021 Apr 29.
3
Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data.
使用机器学习工具亚型和阶段推断(SuStaIn)对病毒性肝炎患者的肝纤维化进展进行建模。
Cureus. 2025 Feb 8;17(2):e78744. doi: 10.7759/cureus.78744. eCollection 2025 Feb.
4
Tracking Cognitive Trajectories in Mild Cognitive Impairment Using a Machine Learning Technique of Subtype and Stage Inference.使用亚型和阶段推断的机器学习技术追踪轻度认知障碍中的认知轨迹。
Dement Neurocogn Disord. 2025 Jan;24(1):44-53. doi: 10.12779/dnd.2025.24.1.44. Epub 2025 Jan 7.
5
Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson's disease.帕金森病中神经元、星形胶质细胞和少突胶质细胞α-突触核蛋白病理的神经病理学阶段。
Acta Neuropathol Commun. 2025 Feb 11;13(1):25. doi: 10.1186/s40478-025-01944-x.
6
Identification of metabolic progression and subtypes in progressive supranuclear palsy by PET molecular imaging.通过PET分子成像识别进行性核上性麻痹中的代谢进展和亚型
Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):823-835. doi: 10.1007/s00259-024-06954-w. Epub 2024 Oct 23.
7
The spectrum of behavioral disorders in amyotrophic lateral sclerosis: current view.肌萎缩侧索硬化症中的行为障碍谱:当前观点
J Neural Transm (Vienna). 2025 Feb;132(2):217-236. doi: 10.1007/s00702-024-02841-8. Epub 2024 Oct 14.
8
A federated learning architecture for secure and private neuroimaging analysis.一种用于安全和隐私神经影像分析的联邦学习架构。
Patterns (N Y). 2024 Aug 1;5(8):101031. doi: 10.1016/j.patter.2024.101031. eCollection 2024 Aug 9.
9
Multimodal subtypes identified in Alzheimer's Disease Neuroimaging Initiative participants by missing-data-enabled subtype and stage inference.通过启用缺失数据的亚型和阶段推断在阿尔茨海默病神经影像倡议参与者中识别出的多模态亚型。
Brain Commun. 2024 Jun 25;6(4):fcae219. doi: 10.1093/braincomms/fcae219. eCollection 2024.
10
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.疾病进展建模揭示了路易体型 α-突触核蛋白病理轨迹的异质性。
Nat Commun. 2024 Jun 15;15(1):5133. doi: 10.1038/s41467-024-49402-x.
使用无监督机器学习和 MRI 数据识别多发性硬化症亚型。
Nat Commun. 2021 Apr 6;12(1):2078. doi: 10.1038/s41467-021-22265-2.
4
Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event-based model of disease progression.使用一种新的基于事件的疾病进展模型来估计典型阿尔茨海默病和后部皮质萎缩的认知能力下降序列。
Alzheimers Dement. 2020 Jul;16(7):965-973. doi: 10.1002/alz.12083. Epub 2020 Jun 2.
5
Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods.使用数据驱动方法解析阿尔茨海默病及相关痴呆的异质性。
Biol Psychiatry. 2020 Jul 1;88(1):70-82. doi: 10.1016/j.biopsych.2020.01.016. Epub 2020 Jan 31.
6
Biological subtypes of Alzheimer disease: A systematic review and meta-analysis.阿尔茨海默病的生物学亚型:系统评价和荟萃分析。
Neurology. 2020 Mar 10;94(10):436-448. doi: 10.1212/WNL.0000000000009058. Epub 2020 Feb 11.
7
Disease Progression Modeling in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的疾病进展建模。
Am J Respir Crit Care Med. 2020 Feb 1;201(3):294-302. doi: 10.1164/rccm.201908-1600OC.
8
DIVE: A spatiotemporal progression model of brain pathology in neurodegenerative disorders.DIVE:神经退行性疾病中脑病理的时空进展模型。
Neuroimage. 2019 May 15;192:166-177. doi: 10.1016/j.neuroimage.2019.02.053. Epub 2019 Mar 4.
9
Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.遗传数据与认知定义的晚发性阿尔茨海默病亚组
Mol Psychiatry. 2020 Nov;25(11):2942-2951. doi: 10.1038/s41380-018-0298-8. Epub 2018 Dec 4.
10
Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling.基于判别事件的阿尔茨海默病疾病进展时间线估计。
Neuroimage. 2019 Feb 1;186:518-532. doi: 10.1016/j.neuroimage.2018.11.024. Epub 2018 Nov 22.